FREYNE EDDY JEAN EDGARD has a total of 13 patent applications. Its first patent ever was published in 1994. It filed its patents most often in United States and Republic of Korea. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are N30 PHARMACEUTICALS LLC, N30 PHARMACEUTICALS INC and DELAGRANGE LAB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Freyne Eddy Jean Edgard | 12 |
#2 | Willems Marc | 6 |
#3 | Embrechts Werner Constant Johan | 6 |
#4 | Perera Timothy Pietro Suren | 5 |
#5 | Rombouts Frederik Jan Rita | 3 |
#6 | Van Emelen Kristof | 3 |
#7 | Ten Holte Peter | 2 |
#8 | Storck Pierre Henri | 2 |
#9 | Janicot Michel Marie Francois | 2 |
#10 | Poncelet Virginie Sophie | 2 |
Publication | Filing date | Title |
---|---|---|
US2008153853A1 | Use of mtki 1 for treating or preventing brain cancer | |
US2008213275A1 | Use of mtki 1 for treating or preventing bone cancer |